Free Trial

Pear Therapeutics (PEAR) News Today

Pear Therapeutics (PEARQ) Earnings Dates & Reports
Acorda: Q1 Earnings Snapshot
Pear Therapeutics Inc Class A PEARQ
PEARQ Pear Therapeutics, Inc.
Pear Therapeutics, Inc. (PEARQ)
Pear Therapeutics sold for parts
Seres Therapeutics (MCRB) Gets a Buy from Chardan Capital
Pear Therapeutics Inc (PEARQ)
Chardan Capital Remains a Buy on Omega Therapeutics (OMGA)
Get Pear Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PEAR and its competitors with MarketBeat's FREE daily newsletter.

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

PEAR Media Mentions By Week

PEAR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PEAR
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

PEAR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PEAR Articles
This Week

1

0

PEAR Articles
Average Week

Get Pear Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PEAR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PEAR) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners